Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives. 2003

Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
Université Blaise Pascal, Synthèse et Etude de Systèmes à Intérêt Biologique, UMR 6504, 63177, Aubière, France.

In the course of structure-activity relationship studies, new rebeccamycin derivatives substituted in 3,9-positions on the indolocarbazole framework, and a 2',3'-anhydro derivative were prepared by semi-synthesis from rebeccamycin. The antiproliferative activities against nine tumor cell lines were determined and the effect on the cell cycle of murine leukemia L1210 cells was examined. Their DNA binding properties and inhibitory properties toward topoisomerase I and three kinases PKCzeta, CDK1/cyclin B, CDK5/p25 and a phosphatase cdc25A were evaluated. The 3,9-dihydroxy derivative is the most efficient compound of this series toward CDK1/cyclin B and CDK5/p25. It is also characterized as a DNA binding topoisomerase I poison. Its broad spectrum of molecular activities likely accounts for its cytotoxic potential. This compound which displays a tumor cell line-selectivity may represent a new lead for subsequent drug design in this series of glycosylated indolocarbazoles.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D010770 Phosphotransferases A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7. Kinases,Phosphotransferase,Phosphotransferases, ATP,Transphosphorylase,Transphosphorylases,Kinase,ATP Phosphotransferases
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013057 Spectrum Analysis The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Spectroscopy,Analysis, Spectrum,Spectrometry
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
April 2017, Bioorganic chemistry,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
May 2013, Medicinal chemistry (Shariqah (United Arab Emirates)),
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
November 2013, Bioorganic & medicinal chemistry,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
June 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
May 2002, European journal of medicinal chemistry,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
August 2011, Bioorganic & medicinal chemistry letters,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
April 2008, Bioorganic & medicinal chemistry,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
March 2002, Journal of medicinal chemistry,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
December 2004, Bioorganic & medicinal chemistry,
Pascale Moreau, and Nathalie Gaillard, and Christelle Marminon, and Fabrice Anizon, and Nathalie Dias, and Brigitte Baldeyrou, and Christian Bailly, and Alain Pierré, and John Hickman, and Bruno Pfeiffer, and Pierre Renard, and Michelle Prudhomme
January 2017, Anti-cancer agents in medicinal chemistry,
Copied contents to your clipboard!